Antonio Di Biagio

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 371 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Week 48 +14

Bloodstream infections in critically ill patients with COVID‐19

Daniele Roberto Giacobbe, Denise Battaglini, Lorenzo Ball et al. · European Journal of Clinical Investigation · 2020 · 316 citations · Full text

ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population

Elisa Benetti, Rossella Tita, Ottavia Spiga et al. · European Journal of Human Genetics · 2020 · 267 citations · Full text

Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

Chiara Fallerini, Sergio Daga, Stefania Mantovani et al. · eLife · 2021 · 207 citations · Full text

The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring

Giorgio Gatti, Antonio Di Biagio, R Casazza et al. · AIDS · 1999 · 176 citations